Merck & Company, Inc. News Headlines

MRK 
$58.21
*  
0.10
0.17%
Get MRK Alerts
*Delayed - data as of Jul. 24, 2014  -  Find a broker to begin trading MRK now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Short-Term Bulls Take Over Merck Options Pits
9/26/2013 3:40:00 PM - Minyanville

Does Conatus Pharmaceuticals Have A Winner With Emricasan?
9/25/2013 6:21:00 PM - Seeking Alpha

Sugammadex's Problems: Is The Merck/Schering-Plough Deal The Worst?
9/25/2013 4:40:00 PM - Seeking Alpha

Searching For Yield With Bill Gross
9/25/2013 11:23:00 AM - Seeking Alpha

Encouraging Data on Dapagliflozin - Analyst Blog
9/25/2013 11:17:53 AM - Zacks.com

3 Biotech Stocks To Trade But For Different Reasons
9/24/2013 1:19:00 PM - Seeking Alpha

3 Companies On The Forefront Of Cancer Immunotherapy Innovations
9/24/2013 12:14:00 PM - Seeking Alpha

Regulatory Setback for Merck - Analyst Blog
9/24/2013 11:18:07 AM - Zacks.com

Amgen: US Filgrastim Patent Challenge
9/23/2013 11:18:00 AM - Seeking Alpha

Biotech Chimerix Lock-Up Expiration
9/23/2013 10:25:00 AM - Seeking Alpha

Top Ten Dow Dogs Flaunt 7.6% To 17.8% September Price Upsides
9/20/2013 6:30:00 PM - Seeking Alpha

Stock Buyback Announcements Slow To $2.3 Billion Daily In Third Quarter
9/20/2013 1:57:00 PM - Seeking Alpha

U.S. Patent Allowance for BioLineRx' BL-8020 - Analyst Blog
9/19/2013 1:20:59 PM - Zacks.com

Eli Lilly And Merck: A Pipeline Of Success?
9/16/2013 3:57:00 PM - Seeking Alpha

Dividend Growth Investing: A Prospective Study
9/16/2013 2:32:00 PM - Seeking Alpha

Niraparib And Rolapitant Will Take Tesaro To New Heights
9/13/2013 3:21:00 PM - Seeking Alpha

AstraZeneca, Merck Ink Licensing Deal - Analyst Blog
9/12/2013 11:40:01 AM - Zacks.com

Is There Much Hope For Merck In Alzheimer's Drug Clinical Trials?
9/11/2013 6:08:00 PM - Seeking Alpha

EC OKs Hospira's Inflectra, Shares up - Analyst Blog
9/11/2013 11:40:01 AM - Zacks.com

China's Diabetes Market Could Become A Big Focus For Pharma Companies
9/11/2013 11:15:00 AM - Seeking Alpha

New CEO Named by Forest Labs - Analyst Blog
9/11/2013 10:57:12 AM - Zacks.com

Dow Tweaks Industrial Average Roster, 3 High-Profile Names Gone
9/10/2013 4:17:00 PM - Seeking Alpha

Is It Time To Dump These 5 Dividend Growth Portfolio Stalwarts?
9/10/2013 8:03:00 AM - Seeking Alpha

Seems Like Old Times
9/6/2013 3:35:00 PM - Seeking Alpha

6 Reasons Advaxis May Be The Best Reward Vs. Risk In Healthcare
9/6/2013 2:47:00 PM - Seeking Alpha